Epicatechin

Overview

Epicatechin ((-)-epicatechin) is a monomeric flavan-3-ol belonging to the broader family of flavonoid polyphenols. It is one of the most abundant bioactive compounds in cacao (Theobroma cacao), and is also present in significant quantities in green tea, apples, grapes, and berries. Epicatechin exists as four stereoisomers, with (-)-epicatechin being the most biologically active and prevalent dietary form. Its bioavailability is relatively high for a polyphenol, with plasma concentrations peaking approximately 2 hours after oral ingestion and metabolites detectable for up to 8 hours.

The cardiovascular benefits of epicatechin are primarily mediated through enhanced nitric oxide (NO) bioavailability. Epicatechin activates endothelial nitric oxide synthase (eNOS) via phosphorylation of the PI3K/Akt pathway and simultaneously inhibits NADPH oxidase, reducing superoxide-mediated NO degradation. This dual mechanism explains the blood pressure-lowering and flow-mediated dilation improvements observed in clinical trials with cacao consumption. In skeletal muscle, epicatechin has attracted attention for its ability to inhibit myostatin and increase follistatin, a ratio change that favors muscle growth and regeneration. Animal studies have demonstrated increased mitochondrial biogenesis, improved exercise capacity, and enhanced muscle structure with epicatechin supplementation.

Emerging research highlights epicatechin's neuroprotective potential through enhancement of brain-derived neurotrophic factor (BDNF) expression, improved cerebral blood flow, and reduction of neuroinflammatory markers. In metabolic health, epicatechin improves insulin sensitivity by modulating GLUT4 translocation and protecting pancreatic beta cells from oxidative stress. The compound also exhibits cardioprotective effects against ischemia-reperfusion injury through activation of mitochondrial KATP channels and the SAFE (survivor activating factor enhancement) pathway, mimicking aspects of ischemic preconditioning.

Mechanism of Action

"

Nitric Oxide–Mediated Vascular and Muscular Effects\n\n(-)-Epicatechin is a flavan-3-ol monomer and the principal bioactive catechin in dark chocolate, green tea, and grape seeds. It enhances endothelial nitric oxide synthase (eNOS) activity through dual mechanisms: (1) activation of PI3K/Akt signaling leading to phosphorylation of eNOS at Ser1177, and (2) inhibition of NADPH oxidase (NOX2) which reduces superoxide (O2•-) generation and prevents NO scavenging to form peroxynitrite. The resulting increase in NO bioavailability produces vasodilation, reduced blood pressure, and improved flow-mediated dilation (FMD) by 2–3% at doses of 50–200 mg/day. In skeletal muscle, NO activates soluble guanylyl cyclase → cGMP → PKG signaling that enhances calcium handling and muscle contractile efficiency (PMID: 20091554).\n\n

Myostatin Inhibition and Muscle Growth Signaling\n\nEpicatechin decreases myostatin (GDF-8) expression and increases follistatin levels in skeletal muscle, shifting the myostatin:follistatin ratio in favor of muscle growth. Myostatin normally activates ActRIIB → Smad2/3 signaling that suppresses muscle protein synthesis and satellite cell proliferation. By reducing myostatin and increasing its endogenous antagonist follistatin, epicatechin derepresses the Akt/mTORC1/p70S6K anabolic pathway. In aged mice, 15 days of epicatechin treatment (1 mg/kg) increased grip strength by 18% and stimulated mitochondrial biogenesis via PGC-1alpha and TFAM upregulation. Human studies in heart failure patients showed improved hand grip strength and increased skeletal muscle follistatin:myostatin ratio (PMID: 22437137).\n\n

Mitochondrial Biogenesis and Metabolic Enhancement\n\nEpicatechin activates AMPK through CaMKKbeta and LKB1-dependent phosphorylation at Thr172, which deacetylates and activates PGC-1alpha via SIRT1-dependent mechanisms. PGC-1alpha drives transcription of nuclear respiratory factors (NRF-1/2) and mitochondrial transcription factor A (TFAM), stimulating mitochondrial DNA replication and organelle biogenesis. In skeletal muscle, this increases mitochondrial volume density, cristae density, and oxidative phosphorylation capacity. Epicatechin also activates Nrf2-ARE antioxidant signaling, upregulating HO-1, NQO1, and glutathione synthetase. These combined effects improve cellular energy metabolism and redox homeostasis, with particular relevance to age-related mitochondrial dysfunction and sarcopenia (PMID: 24770425)."

Reconstitution Calculator

Research

Safety Profile

Common Side Effects

• Generally well-tolerated at typical dietary and supplemental doses (50–200 mg/day)
• Mild gastrointestinal discomfort including nausea, bloating, or stomach upset, particularly on an empty stomach
• Headache reported occasionally at higher doses
• Potential for mild blood pressure reduction, which may cause lightheadedness in sensitive individuals

Serious Adverse Effects

• No serious adverse events have been reported in clinical trials at standard doses
• Theoretical risk of excessive vasodilation at very high doses, potentially causing hypotension
• High-dose flavanol intake may interfere with iron absorption over time, though this is poorly documented for epicatechin specifically

Contraindications

• Individuals with known hypersensitivity to cacao-derived compounds or catechins should avoid supplementation
• Caution advised in individuals with hypotension or those prone to low blood pressure episodes
• Pregnant and breastfeeding women should limit intake to amounts commonly found in food, as safety of supplemental doses has not been established
• Individuals scheduled for surgery should discontinue use at least two weeks prior due to mild antiplatelet activity

Drug Interactions

• May enhance the effects of antihypertensive medications, increasing the risk of hypotension
• Potential interaction with antiplatelet and anticoagulant drugs (warfarin, aspirin, clopidogrel) due to mild blood-thinning properties
• May affect cytochrome P450 enzyme activity (particularly CYP3A4), potentially altering metabolism of various pharmaceuticals
• Could theoretically potentiate the effects of PDE5 inhibitors (sildenafil, tadalafil) through overlapping nitric oxide signaling pathways
• Iron supplements or iron-rich meals may have reduced absorption when taken concurrently

Population-Specific Considerations

• Older adults should start with lower doses and monitor blood pressure
• Individuals with diabetes should monitor blood glucose, as epicatechin may improve insulin sensitivity
• Those with kidney disease should consult a physician before supplementation

Pharmacokinetic Profile